# A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers

> **NCT02594449** · PHASE4 · UNKNOWN · sponsor: **Lustre Pharmaceutical Lab Co., Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Benzalkonium Chloride Solution

## Key facts

- **NCT ID:** NCT02594449
- **Lead sponsor:** Lustre Pharmaceutical Lab Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594449, "A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02594449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*